Sonoma Pharmaceuticals grants annual options to execs and directors at $1.08 strike

Sonoma Pharmaceuticals, Inc.

Board revised Director Compensation Plan, reducing annual director option grants to 20,000 per director.
CEO Amy Trombly awarded 40,000 options; COO Bruce Thornton 40,000; CFO Chad White 9,753 (prorated).
Exercise price $1.08 per share; options vest in three equal annual tranches over three years.
Options accelerate on change of control and as provided in executive employment agreements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.